<SEC-DOCUMENT>0001193125-21-190157-index.html : 20210614
<SEC-HEADER>0001193125-21-190157.hdr.sgml : 20210614
<ACCEPTANCE-DATETIME>20210614165631
ACCESSION NUMBER:		0001193125-21-190157
CONFORMED SUBMISSION TYPE:	8-A12B
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20210614
DATE AS OF CHANGE:		20210614

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lyell Immunopharma, Inc.
		CENTRAL INDEX KEY:			0001806952
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				833006753
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-A12B
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40502
		FILM NUMBER:		211015237

	BUSINESS ADDRESS:	
		STREET 1:		400 EAST JAMIE COURT
		STREET 2:		SUITE 301
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650 695-0677

	MAIL ADDRESS:	
		STREET 1:		400 EAST JAMIE COURT
		STREET 2:		SUITE 301
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-A12B
<SEQUENCE>1
<FILENAME>d152418d8a12b.htm
<DESCRIPTION>8-A12B
<TEXT>
Document 1 - file: d152418d8a12b.htm

</DOCUMENT>
</SEC-DOCUMENT>